Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-23-060292

Pres&Chief Investment Officer acquired 71,365 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sukhatme Mayukh Pres&Chief Investment Officer 2023-12-27 Option exercise +71,365 3,289,115 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Sukhatme Mayukh Pres&Chief Investment Officer 2023-12-27 Option exercise · Capped Value Appreciation Rights −159,100 $6.40 $1,018,240 1,856,163 D: show line 2 in the form
Sukhatme Mayukh Pres&Chief Investment Officer 2023-12-27 Option exercise · Capped Value Appreciation Rights −28,411 $11.50 $326,727 1,306,889 D: show line 3 in the form
Loading xslF345X05/form4.xml…